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SUMMARY
Gene expression proﬁling is increasingly used in the ﬁeld of infectious diseases for characterization of host, pathogen and
the nature of their interaction. The purpose of this study was to develop a robust, standardized method for comparative
expression proﬁling and molecular characterization of Leishmania donovani clinical isolates. The limitations and possi-
bilities associated with expression proﬁling in intracellular amastigotes and promastigotes were assessed through a series of
comparative experiments in which technical and biological parameters were scrutinized. On a technical level, our results
show that it is essential to use parasite harvesting procedures that involve minimal disturbance of the parasite’s environ-
ment in order to ‘freeze’ gene expression levels instantly; this is particularly a delicate task for intracellular amastigotes and
for speciﬁc ‘sensory’ genes. On the biological level, we demonstrate that gene expression levels ﬂuctuate during in vitro
development of both intracellular amastigotes and promastigotes. We chose to use expression-curves rather than single,
speciﬁc, time-point measurements to capture this biological variation. Intracellular amastigote protocols need further
reﬁnement, but we describe a ﬁrst generation tool for high-throughput comparative molecular characterization of patients’
isolates, based on the changing expression proﬁles of promastigotes during in vitro diﬀerentiation.
Key words: Leishmania (Leishmania) donovani, standardization, comparative expression proﬁling isolates, variation gene
expression.
INTRODUCTION
Gene expression proﬁling is becoming an important
tool to study pathogenesis of infectious diseases as
it allows molecular characterization of the cellular
responses of host and pathogen (Chaussabel et al.
2003; Hromatka et al. 2005; McAleese et al. 2006).
This type of study has become feasible since the
introduction of 2 high-throughput expression pro-
ﬁling techniques: (i) microarrays, used for com-
parative analysis of thousands of genes in distinct
RNA populations (Schena et al. 1995), and (ii)
quantitative real-time PCR (Q-PCR), used for rapid
simultaneous analysis of a speciﬁc set of genes in large
sample collections (Heid et al. 1996; Vandesompele
et al. 2002). Both these techniques are rapidly
gaining popularity in Leishmania studies since the
Leishmania genome sequences have become avail-
able (Duncan, 2004; Ivens et al. 2005; Peacock et al.
2007). However, the interpretation and standardiz-
ation of gene expression studies in Leishmania
might be more challenging in comparison to other
eukaryotes due to the speciﬁc biology of this parasite.
Firstly, most protein-coding genes in Leishmania
are transcribed polycistronically, and mature mRNA
levels appear to be regulated primarily by post-
transcriptional mechanisms such as mRNA stability
(Boucher et al. 2002; Campbell et al. 2003; Clayton,
2002; Martinez-Calvillo et al. 2004). Therefore,
diﬀerences in mRNA abundance are often not as
pronounced as in other organisms where expression
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is regulated at the level of transcription initiation
(Saxena et al. 2003; Akopyants et al. 2004; Almeida
et al. 2004;Duncan et al. 2004).The detection of such
small diﬀerences is technically possible but demands
sensitive and robust assays with strict measures to
ensure reproducibility and quality control.
Secondly, Leishmania continuously changes life-
form throughout its life-cycle (in the vector from
non-infective procyclic to infective metacyclic pro-
mastigotes ; intracellular amastigotes in the host).
This process of diﬀerentiation is associated with
variation in gene expression, which in turn seems to
be triggered by the changing external environment
of the parasite (Shapira et al. 1988; Duncan et al.
2001; Saxena et al. 2007). The diﬀerentiation process
can be mimicked in vitro by changing medium/
environment. Promastigotes grow from early log
phase (procyclic forms) to stationary phase (meta-
cyclic forms) in response to nutrient depletion and
acidiﬁcation of culture medium over 7–8 days (Sacks,
1989; Bates and Tetley, 1993; Zakai et al. 1998).
Intracellular amastigotes initiate transformation to
promastigotes within 1 h after release from the host
cell (Fong and Chang, 1981). Previous studies have
proven that gene expression/protein proﬁles vary
considerably during the above-described in vitro
diﬀerentiation (Akopyants et al. 2004; Holzer et al.
2006;McNicoll et al. 2006; Cohen-Freue et al. 2007;
Saxena et al. 2007). Consequently, when comparing
diﬀerent Leishmania strains using gene expression
proﬁles, it is of major importance to ensure that
the studied parasites from the various strains (i) are in
a similar in vitro diﬀerentiation stage and (ii) are
obtained with in vitro manipulation techniques in-
volving minimal disturbance of the parasite’s en-
vironment to minimize impact on expression proﬁle.
In this study we speciﬁcally wanted to explore the
possibilities, requirements and limitations of gene
expression proﬁling when used for molecular
comparison of multiple Leishmania isolates from
patients. We veriﬁed the impact of changing bio-
logical (diﬀerentiation stage) and technical (in vitro
manipulation methods) parameters on expression
levels of genes encoding for proteins with diverse
functions. The results could be translated into
guidelines for design of reliable comparative gene
expression assays useful for high-throughput charac-
terization of patient’s isolates. Furthermore, this
study also highlights some issues that might help the
interpretation and comparison of other studies on
Leishmania gene expression.
MATERIALS AND METHODS
Parasites
The L. (L.) donovani isolates BPK206/0, BPK091/0,
BPK087/0, and BPK190/0 were obtained from
bone-marrow aspirates from conﬁrmed visceral
leishmaniasis patients recruited at the B.P. Koirala
Institute of Health Sciences, Dharan, Nepal.
Leishmania species identiﬁcation was done by PCR-
RFLP analysis of cysteine proteinase B as reported
elsewhere (Tintaya et al. 2004). The uncloned iso-
lates were tested as intracellular amastigotes for
their in vitro antimonial susceptibility within 8 in
vitro passages after isolation from patients, as de-
scribed before (Rijal et al. 2007). Isolates BPK206/0
and BPK091/0 were characterized as SbV sensitive,
and BPK087/0 and BPK190/0 as SbV resistant.
These isolates were used here for gene expression
analysis within a maximum of 15 in vitro passages
after isolation from patients.
In vitro promastigote generation
Two protocols were used in this study for the
generation of promastigotes. (1) Rapid growth on
blood agar. Promastigotes were grown in Tobie’s
blood agar medium (Tobie et al. 1950) with a saline
overlay at 26 xC. This rich medium supports pro-
mastigote growth and diﬀerentiation from procyclic
to metacyclic stage in 3–4 days. The resulting cul-
tures were harvested when the stationary phase was
reached as determined by microscopical evaluation
of morphology and parasite density. The overlay of
the resulting culture was removed and washed 3
times with PBS to remove contaminating material
originating from the blood agar. (2) Controlled
growth on Eagle’s medium. Promastigotes were
grown on modiﬁed Eagle’s medium (Mottram et al.
1992) (Invitrogen) supplemented with 20% (v/v)
heat-inactivated foetal calf serum (PAALaboratories
GmbH), pH 7.5, at 26 xCover 7–8 days. The cultures
were initiated by inoculating metacyclic parasites
(at day 3–4 stationary phase) in 5 ml of culture
medium at a ﬁnal concentration of 5r105 parasites/
ml. The parasite density was determined every 24 h
using disposable count chambers Uriglass (Menarini
diagnostics) to follow up the growth and diﬀeren-
tiation proﬁle. Parasites were harvested at diﬀerent
time-points of the growth curves (speciﬁc time-
points per experiment are speciﬁed in the text) by
centrifugation and the resulting pellet was washed
once with PBS. An identical batch of culturemedium
and foetal calf serum was used for all promastigote
cultures in this study, to minimize variation in
culture conditions.
In vitro intracellular amastigote generation
Murine peritoneal macrophages were infected with
promastigotes at the third day stationary phase
(as determined by the concomitant growth curve,
see above ‘controlled growth Eagle’s medium’) at a
ratio of 7 promastigotes to 1 macrophage as de-
scribed elsewhere (Decuypere et al. 2005) ; for all
experiments,>80% of macrophages were infected at
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24 h. The harvest of the in vitro-generated amasti-
gotes was done at several time-points post-infection
according to one of the following 2 protocols. (1)
Puriﬁcation of amastigotes by SDS lysis of macro-
phages. The adherent, infected macrophages were
washed with ice-cold PBS to remove extracellular
promastigotes. Three ml of 0.0125% SDS/PBS were
added to each 25 cm2 culture ﬂask, and gently
agitated until macrophages lifted and started to dis-
integrate. After dilution with PBS and mixing,
the contents of each ﬂask were aspirated through a
25G needle, causing further shearing of the macro-
phages, and transferred to a 50 ml tube for centri-
fugation and 2 washing steps in PBS to remove
macrophage debris. (2) Co-harvest of amastigotes/
macrophages. The adherent, infected macrophages
were washed with RPMI 1640 (pre-heated to 37 xC)
to remove residual promastigote debris. The infected
macrophages were subsequently dissociated from
the culture vessels by treatment with TrypLE Select
(Invitrogen) for 9 min at 37 xC as recommended by
the manufacturer. The resulting cell suspension was
immediately diluted 15 times with either RPMI 1640
or the buﬀer PSGEMKA (speciﬁed per experiment
in the text). The buﬀer PSGEMKAwas described to
stall transformation of free amastigotes to promasti-
gotes (Hart et al. 1981). The surface of the culture
ﬂask was carefully scraped with a cell scraper to lift
loosely attached macrophages. The resulting sus-
pension was transferred to a 50 ml tube for centri-
fugation and washed once using the same buﬀer as in
the previous step. Thewhole procedure was carefully
timed and ﬁnished in 30–35 min.
RNA isolation/analysis and real-time
quantitative PCR
After the last washing step all harvested cultures
were immediately disrupted in RNAqueous Lysis/
Binding solution (Ambion) and frozen at x80 xC
until RNA extraction. Total RNA was extracted,
treated and analysed as described before (Decuypere
et al. 2005). Reverse transcription of total RNA and
expression proﬁling of the genes listed in Table 1
were performed as described elsewhere (Decuypere
et al. 2005). All primers speciﬁcally amplify Leish-
mania cDNA as conﬁrmed by quantitative assays
on artiﬁcial Leishmania :macrophage cDNA mix-
tures with variable ratios between 1 : 1 and 1 : 30.
Normalization of gene expression was done by de-
termining the 4 most stable expressed genes from
the set of 13 tested genes (Table 1), as described
elsewhere (Vandesompele et al. 2002). Multiple
Q-PCR runs of one particular experiment were
calibrated (based on 3 samples included in each run
for that purpose), organized and processed using
qBase, a VBA application for MS Excel designed for
the management and automated analysis of real-time
quantitative PCR data (Hellemans et al. 2007).
Quantitative data of independent experiments were
compared by determining the expression variation
measure as described below.
Deﬁnition expression variation measure (EVM) and
technical variation threshold (TVT)
The expression variation measure (EVM) assesses a
sample’s variation in gene expression levels between
repeated independent experiments. The mathemat-
ical background of EVM is outlined below.
If for 2 samples A and B, the relative expression
level of a particular gene G is determined in 2 inde-
pendent experiments X and Y, then the results of
the two experiments can only be compared indirectly
by considering the ratios:
for exp: X:
ax
bx
for exp: Y:
ay
by
ax=y=sample A’s relative expression level of gene G
in exp: x=y
bx=y=sample B’s relative expression level of gene G
in exp: x=y
The diﬀerence between these two ratios indicates
that gene G expression levels varied between the two
experiments, either in one sample, or in both samples
to a diﬀerent degree. The more the two ratios diﬀer,
or, expressed in mathematical terms, the higher the
value of the expression
st: dev: log2
ax
bx
 
, log2
ay
by
  
;
(1)
themore geneG expression levels varied between the
independent experiments for samples A/B.
Interpolation in function (1) of all ‘gene G’-ratios
involving (i) sample A and (ii) every other sample
included in experiments X and Y results in a func-
tion that summarizes sample A’s individual inter-
experimental variation in gene G expression level.
For sampleA (ofN samples in experimentsX andY),
this function is mathematically represented by the
array:
8A, K 2 [1, N] and AlK:
st: dev: log2
ax
kx
 
, log2
ay
ky
   
k=1!n
ax=y=sample A’s relative expression level of gene G
in exp: x=y
kx=y=sample K’s relative expression level of gene G
in exp: x=y
nx=y=sample N’s relative expression level of gene G
in exp: x=y
The average of this array was deﬁned in this study
as the EVM of sample A for gene G between exper-
iment X and Y.
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Table 1. Overview primer design and PCR conditions for quantitative PCR
Gene Coding for … Function/Relevance Sequence Forward/Reverse Primera Fin. conc.
AQP1 aquaglyceroporin 1 integrated membrane channel for transport
water and small solutes
LinJ31.0020 5k CTGTGTCTTTGGTGCCTTTCC 3k 400 nM
5k GCCTTTTGGGCGTCGTC 3k
MRPA multidrug resistance protein A intracellular ABC transporter, presumably
involved in sequestration metal-thiol conjugates
LinJ23.0290 5k CGAAAGTTGAGCAGGAGACG 3k 300 nM
5k AATCCCCAAGCAGCCAGAC 3k
PRP1 pentamidine resistance protein 1 intracellular ABC transporter involved in
pentamidine resistance
LinJ31.1810 5k TGATTCCCTTTTTGGGCATTA 3k 400 nM
5k CGTAGAACTTGAGCAGGAGCAC 3k
ACR2 arsenate reductase 2 protein tyrosine phosphatase activity and metal
reductase activity in presence of glutathione
LinJ32.3240 5k GCCCAGTCGCTCATACGG 3k 400 nM
5k AGAACGCCTCCCACCCAC 3k
TDR1 thiol dependent reductase 1 homologue of glutathione S-transferase LinJ33.0270 5k GTGGCGAGGATGCGAAGG 3k 500 nM
5k CGGACCAGGAAAGGTAGAATAGC 3k
CS cysteine synthase enzyme for de novo cysteine biosynthesis
from serine
LinJ36.3190 5k GTCTTGGCGGTTCAGTTCG 3k 500 nM
5k GACATTGTGGTTCGTCTGCTC 3k
CBS cystathione b-synthase enzyme in cysteine synthesis from
homocysteine via trans-sulphuration pathway
LinJ17.0280 5k CGCCGATGTCAACTGGATG 3k 300 nM
5k GCTCCTTCTTCAGCGTGTCG 3k
SAT serine acetyltransferase enzyme in de novo cysteine biosynthesis
from serine
LinJ34.2490 5k CCCGTATGCTGACAGAGTTGG 3k 400 nM
5k GCCGTGGTGAATGAAGAAGTG 3k
GCS c-glutamylcysteine synthase key enzyme in glutathione biosynthesis AY371486b 5k TTTGCGTCCTGGTGCCTC 3k 500 nM
5k TCAATGTTTAGTTGGGGGTCC 3k
ODC ornithine decarboxylase key enzyme in spermidine biosynthesis M81192b 5k ATCCACCTCCAACCCGC 3k 500 nM
5k TCCGCAACAGCAACAACAG 3k
TR trypanothione reductase central oxidoreductase for maintenance cellular
redox potential
Z23135b 5k GGCGAGGTTCTGGGTGTTC 3k 300 nM
5k GACTCCGATGGTGCTGTGG 3k
MST mercapto-pyruvaat
sulfurtransferase
assimilatory sulphur reduction and putative role
in detoxiﬁcation ROS via thioredoxin oxidation
LinJ05.0980 5k GGAGGAGAACCGCCACAAC 3k 500 nM
5k GCCGCAGGAGAAGACGAAG 3k
S8 ribosomal protein S8 structural constituent of large subunit ribosome LinJ24.1470 5k GCAGACAGGAAGACCACCAAG 3k 400 nM
5k AGCGGCGTGGACGGACT 3k
a=all primers were Leishmania speciﬁc; b=GenBank annotation, all other sequence no. as annotated in L. (L.) infantum GeneDB.
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Part of a sample’s inter-experimental variation
comprised in EVM will be caused by technical
variation between the experiments. This technical
variation depends on RT, PCR eﬃciency, PCR
sensitivity, etc and is thus characteristic for each
particular gene expression assay. The technical
variation for each gene expression assay was assessed
here by testing 8 samples in 4 technical repeated
(=using identical RNA source) experiments. The
average of the resulting 8 EVMs/gene reﬂects
the inter-experimental technical variation for each
gene expression assay. Or, extrapolating according
to the Gaussian distribution, 95% of technically re-
peated samples would have an EVM smaller than:
P8
i=1 EVMi
8
+196rst: dev {EVMi}i=1!8=TVTG
EVMi=EVM of sample i between 4 technical
repeated assays for gene G;
which was here deﬁned as technical variation
threshold (TVT) of the expression assay of gene G.
Interpretation EVM and TVT
If EVM of sample A for gene G is lower than TVT of
the expression assay for that gene G, the observed
variation in expression level between experiments
does not exceed the expected technical variation, and
it is likely that sample A did not vary on the biological
level for gene G expression between the independent
experiments.
If EVM of sample A for gene G is higher than
TVT of the expression assay for that gene G, the
observed variation in expression level between
experiments is higher than expected by technical
variation, and it is likely that sample A varied on the
biological level for gene G expression between the
independent experiments.
Wemust emphasize, however, that EVM/TVT is a
rough estimation of the biological expression vari-
ation in repeated independent experiments. As, ﬁrst
of all, TVT is only based on a limited number (4) of
technical repeats and thus only an approximation of
the actual technical variation of a gene expression
assay; secondly, an EVMbelowTVT is no guarantee
that there was only technical variation; as the bio-
logical variation between 2 particular experiments
could be lower than TVT as well; and thirdly, EVM
does not take into account the variability of the nor-
malization factor, which, characteristic for it’s stable
nature, is minimal and constant through all samples.
RESULTS
Exploring the limitations of Leishmania gene
expression proﬁling: inﬂuence of cultivation and
harvesting protocols
The ﬁrst aim of this study was to explore the impact
of variable in vitro manipulation techniques on gene
expression in both promastigotes and amastigotes.
We therefore performed 2 independent experiments
for expression proﬁling of 8 genes in promastigotes
and amastigotes of 4 L. (L.) donovani strains. The
2 experiments, referred to as Experiments A and B,
diﬀered in protocols for parasite culturing and
harvesting (details are listed in Fig. 1A). The 8
‘target ’ genes encode proteins with diﬀerent func-
tions (Table 1), including (i) transport (AQP1,
MRPA), (ii) redox metabolism (GCS, ODC, TR),
(iii) cellular reduction (TDR1, ACR2) and (iv)
ribosomal function (S8). This allowed us to verify
if various cellular functions are aﬀected to diﬀerent
extents at gene expression level by varying exper-
imental conditions.
We introduced the expression variation measure
(EVM) and technical variation threshold (TVT)
to assess a sample’s inter-experimental biological
variation at the level of gene expression (see the
Materials and Methods section). The EVMs of all
samples based on the expression levels obtained
in Experiments A and B are graphically depicted in
Fig. 1B. Firstly, the graph clearly indicates that
there was biological variation between the two
experiments; with EVMs higher than TVT for sev-
eral amastigote and promastigote samples. Secondly,
the biological variation aﬀected the expression of
the various genes to a diﬀerent extent, exempliﬁed
by the proﬁles of AQP1, GCS and TDR1. (i) For
AQP1, the expression levels of all amastigote and
promastigote samples showed biological variation
between the two experiments (all EVMs>TVT).
The actual AQP1 expression proﬁles of the 4 iso-
lates (promastigotes and amastigotes) obtained in
Experiments A and B are depicted in Fig. 1C and
demonstrate the extent of diﬀerences between the
two experiments. (ii) The expression proﬁles of
GCS showed a similar problem, but only on the
level of amastigotes (all amastigote EVMs>TVT);
promastigote results were similar in both experi-
ments (all promastigote EVMs <TVT). Fig. 1D
graphically illustrates the similar promastigote and
dissimilar amastigote GCS expression proﬁles of
Experiments A and B. (iii) In contrast, the expression
of geneTDR1 in both promastigotes and amastigotes
was not aﬀected by the variation between the two
experiments, resulting in similar expression proﬁles
(all EVMs<TVT; Fig. 1E).
Identifying biological and technical sources of
variation gene expression in Leishmania
Intracellular amastigotes. We further focused on
optimization and standardization of the simple and
rapid harvest method used in Experiment B, a pro-
tocol which also seems favourable from a biological
point of view (minimal disturbance of intracellular
parasite environment). We veriﬁed the inﬂuence of
the following 3 parameters on expression of 13 genes
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(A) Differences in vitro manipulation between Experiments A and B (B) EVMs between Experiments A and B for 8 genes in 4 L. (L.) donovani isolates (each isolate 
presented by 1 rectangle for prom. and 1 circle for amas.) 
promastigotes experiment A experiment B
culture medium
Tobie’s blood agar
& saline overlay
Eagle’s medium
+ 20% HIFCS
time of harvest approx. start stationary phase
3 days stationary phase as
determined by growth curve
amastigotes experiment A experiment B 
harvest technique
SDS/needle purification
from mΦ
co-harvest macrophage in
RPMI 1640 
time-span harvest 1-4 hrs 30-35 min
 
(C) AQP1 (D) GCS (E) TDR1
Fig. 1. Summary of gene expression analysis of Leishmania (L.) donovani promastigotes and intracellular amastigotes using diﬀerent in vitro manipulation techniques.
(C–D) Comparison expression levels (¡S.D.) of the same strains (promastigotes=white bars, amastigotes=grey bars) in independent Experiments A and B; white buttons
inside bars indicate sample’s EVM, with 1 button=>than TVT but<than 2r TVT; 2 buttons=o2r TVT; expression levels/gene rescaled to the respective sample with
lowest EVM between Exp. A and Exp. B.
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(Table 1) in L. (L.) donovani in vitro infected in
peritoneal macrophages. (i) Time post-infection
macrophages (24 h, 48 h, 72 h, 120 h). Upon in-
fection of macrophages, metacyclic promastigotes
gradually transform into amastigotes; the rate of
this diﬀerentiation (and adjusting gene expression)
possibly varies between strains. We followed the
biological changes in gene expression during the ﬁrst
120 h post-infection (all harvests in PSGEMKA).
(ii) Buﬀer used during harvest (RPMI 1640 or
PSGEMKA). Manipulation of infected macro-
phages inevitably involves some shearing, which
results in release of amastigotes (observed by micro-
scopy). The buﬀer used during harvest could inﬂu-
ence gene expression of those released amastigotes
and perhaps of the intracellular amastigotes too.
We compared 2 buﬀers in parallel harvests at 48 h
post-infection: RPMI 1640, which is the basis of
the medium (commercially available) used for
macrophage cultures, and PSGEMKA (home-made)
which was reported to preserve the biological
status of amastigotes (Hart et al. 1981). (iii) Harvest
time-span: the procedure is normally ﬁnished in
30–35 min; but variation inmanipulation timemight
aﬀect expression proﬁles.We veriﬁed the inﬂuence of
harvest time-span by comparing expression proﬁles
of 2 parallel harvests at 48 h post-infection including
one ‘short ’ harvest (the normal 30–35 min) and
and ‘long’ harvest (normal harvest with additional
45 min incubation at 4 xC). This comparison was
done for both buﬀer systems.
All conditions were tested on a single large-scale
infection (2 ﬂasks/condition), thus ensuring uniform
quality of in vitro infections in the various tested
conditions. This experiment was performed in
2 strains, BPK206/0 (SbV sensitive) and BPK190/0
(SbV resistant), and the comparative expression
proﬁles were determined in 1 quantitative exper-
iment. As expected, the diﬀerent parameters inﬂu-
enced the expression of the 13 genes to a variable
extent. (i) Nine out of 13 genes showed a variable
expression at the diﬀerent biological time-points and
(ii) 6 out of 13 genes had variable expression levels at
48 h post-infection when either diﬀerent buﬀers or
diﬀerent harvest time-spans were used. Overall, we
identiﬁed 3 types of proﬁles that are represented
by AQP1, GCS and TDR1 (Fig. 2).
(i) AQP1 expression was found to be very unstable,
which agrees with the results discussed in the pre-
vious section. The expression levels of BPK190/0
diﬀered signiﬁcantly between the diﬀerent biological
time-points (24–120 h post-infection) and between
the diﬀerent technical conditions (PSGEMKA vs
RPMI 1640, two harvest time-spans, see Fig. 2A).
We could not even reproduce the AQP1 expression
proﬁle of BPK190/0 in 2 biologically repeated
harvests with identical conditions (data not shown).
(ii) The proﬁle of GCS also showed considerable
variation at the diﬀerent biological time-points,
particularly for BPK190/0; but all the technical
conditions tested at 48 h post-infection gave repro-
ducible results (Fig. 2B).
(iii) The expression of TDR1 was similar at all
biological time-points and was not aﬀected by vary-
ing technical parameters, which tallies with the
results of the previous section (Fig. 2C).
Furthermore, the variability of expression for dif-
ferent biological and technical conditions seems to be
strain dependent. Fig. 2 shows a contrasting picture
of a ‘stable ’ BPK206/0 proﬁle versus a ‘variable’
BPK190/0 proﬁle. This diﬀerence in stability of gene
expression levels might reﬂect a diﬀerence in cellular
ﬂexibility. BPK190/0 and BPK206/0 are genetically
closely related (Laurent et al. 2007), but diﬀer in
many phenotypic aspects, including in vitro SbV and
SbIII susceptibility (Rijal et al. 2007), which could
indeed be linked to diﬀerential cellular response
ability. This inter-strain variation highlights the
importance of choosing representative reference
strains when standardizing such protocols.
Promastigotes. The ﬁrst section demonstrated that
the expression proﬁles of promastigotes also varied
between Experiments A and B (Fig. 1).We suspected
that these diﬀerences were due to unsynchronized
harvesting during the gradual diﬀerentiation process
of cultured promastigotes. Consequently, we chose
the protocol ‘controlled growth on Eagle’s medium’
(see the Materials and Methods section) for further
standardization of promastigote expression pro-
ﬁling. Promastigotes were harvested every 24 h for
8 days for the 2 strains BPK206/0 and BPK190/0.
The expression proﬁles of 13 genes (Table 1) were
determined for all time-points in 1 quantitative
experiment (see Supplemental material with Online
version of paper). The in vitro diﬀerentiation process
of the promastigotes could be synchronized for the
two strains based on the concomitantly determined
growth curve. The ﬁrst day of stationary phase
served as a reference point and was arbitrarily de-
signated as time-point 0 h. The matching expression
proﬁles of the 24-hourly harvests could then be
translated into synchronized ‘expression-curves’.
These expression-curves reﬂect the gene expression
variation during diﬀerentiation over 8 days, and the
type of proﬁles obtained for the 13 genes are once
more exempliﬁed by AQP1, GCS and TDR1. (i)
Expression of AQP1 was relatively stable during the
multiplicative phase, but rose sharply during the
stationary phase with ¡3-fold diﬀerence between
ﬁrst (0 h) and second (24 h) day (Fig. 3A). This
ﬁnding explains the variation between Experiments
A and B, which both investigated stationary phase
promastigotes in the absence of synchronization. (ii)
The proﬁle of GCS was similar to AQP1, but the
expression increase was much less pronounced
(¡1.5-fold diﬀerence between 0 and 24 h) (Fig. 3B).
(iii) The last gene, TDR1, showed little variation
Expression proﬁling of L. (L.) donovani 189
over the whole promastigote diﬀerentiation pro-
cess (Fig. 3C), this is also in agreement with Exper-
iment A/B.
Just as with amastigotes, the degree of biological
variation of expression during in vitro diﬀerentiation
varies between diﬀerent strains; this is clearly shown
by the signiﬁcant diﬀerence between BPK190/0 and
BPK206/0 for AQP1.
The expression-curves of the 2 strains could be
reproduced in a biological repeated experiment
(A) AQP1
(B) GCS
(C) TDR1
Fig. 2. Summary of expression proﬁling of Leishmania (L.) donovani intracellular amastigotes of the isolates BPK206/0
(SbV sensitive) and BPK190/0 (SbV resistant). Relative gene expression levels determined in variable biological
conditions (l time-points of in vitro macrophage infections, grey bars) and using variable techniques (l harvest
conditions at time point 48 h, white bars). A single large-scale macrophage infection with each isolate was used to test
all conditions shown; expression levels were rescaled/gene versus sample with lowest expression, error bars=S.D.
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(A) AQP1 (B) GCS (C) TDR1
(D) EVMs promastigotes (8 time-points, 2 strains) for 8 genes
between 2 biological repeated independent experiments both
following ‘controlled growth on Eagle’s medium’-protocol
Fig. 3. Summary of expression proﬁling of Leishmania (L.) donovani promastigotes of the isolates BPK206/0 (SbV sensitive) and BPK190/0 (SbV resistant). (A–C) Expression-
curves reﬂecting biological variation in gene expression throughout in vitro promastigote diﬀerentiation; full lines and dotted lines (rep.) represent 2 biological repeated
independent experiments. Total time-scale of 8 days with 0 h=1st day stationary phase according to concomitant growth curve; all expression levels/gene were rescaled versus
sample with lowest expression in the respective experiment, error bars=S.D.
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(dotted curves in Fig. 3A–C), even for AQP1. The
2 repeated independent experiments were scruti-
nized for inter-experimental biological variation
by determining the EVM for 128 samples (8 time-
pointsr2 strainsr8 genes), analogous to experiment
A/B. We only identiﬁed 2 out of 128 samples with
an EVM>TVT (versus 7/32 for promastigotes
Experiment A/B) and there were no indications of
consistent variation problems in any of the 8 genes
(Fig. 3D).
DISCUSSION
Biochemical and molecular characterization of
intracellular amastigotes has always been delicate,
as puriﬁcation of amastigotes from macrophages is
usually required. Diﬀerent methods of amastigote
puriﬁcation were reported in the past (Hart et al.
1981; Monjour et al. 1984; Pham and Mauel, 1987),
but all involve long procedures (>1 h) and expose the
amastigotes to chemical or physical strain. Hence,
these techniquesmight inﬂuence the biological status
(including gene expression proﬁles) of freed amasti-
gotes as it is well-established that changes in en-
vironment rapidly (<1 h) trigger transformation to
promastigotes (Fong and Chang, 1981; Duncan et al.
2001; Barak et al. 2005).
In this study, we used gene expression proﬁling
for molecular characterization of intracellular
amastigotes and introduced a new harvest-technique
that omits the puriﬁcation step (co-harvest amasti-
gotes and macrophages). It was demonstrated, that
even in the absence of amastigote puriﬁcation, other
technical parameters of the harvest procedure
(e.g. type of buﬀer, time-span harvest) can still aﬀect
the expression proﬁles of co-harvested intracellular
amastigotes (observed for 6 out of 13 tested genes).
This was clearly exempliﬁed by the unstable ex-
pression proﬁle of the gene AQP1, which encodes
a membrane channel thought to be involved in
regulation of osmotic stress (Beitz, 2005). Possibly
the expression proﬁle of AQP1 continuously adjusts
during in vitro manipulations in response to minor
changes in medium/buﬀer, temperature, pH, etc.
Such a ‘sensory’ regulation could impede repro-
ducible AQP1 expression proﬁling of amastigotes
regardless of the technique applied for harvest.
We also established that expression proﬁles of
in vitro generated intracellular amastigotes ﬂuctuate
signiﬁcantly during the ﬁrst 120 h post-infection
(observed for 9 out of 13 genes). We suspect that
this expression variation is, at least in part, associated
with the ongoing transformation from promasti-
gotes to amastigotes in those 5 days post-infection.
A recent study on L. (L.) donovani reported similar
ﬁndings during the transformation of promastigotes
to axenic amastigotes (Saxena et al. 2007). The rate
of this transformation process could vary between
diﬀerent isolates, thus there is no guarantee that
various isolates reach identical transformation
stages at any particular time-point in the ﬁrst 120 h
post-infection. A reliable molecular comparison of
intracellular amastigotes should compare identical
developmental stages and it seems therefore advis-
able to compare multiple time-points (in the form
of expression-curves, as done here for promastigotes)
in stead of 1 time-point.
These ﬁndings imply that comparison of results
of various Leishmania amastigote gene expression
studies needs to be done with extreme care if the
studies use diﬀerent in vitro manipulation proto-
cols. For example, our previous molecular report
on L. (L.) donovani SbV resistance was based on
Experiment A and suggested that reduced expression
of AQP1 and GCS in amastigotes was possibly a
speciﬁc feature of SbV-resistant isolates (Exp. A,
Fig. 1) (Decuypere et al. 2005). However, now
we obtained diﬀerent results in the independent
Experiment B, which diﬀered in in vitro manipu-
lation protocol.We could argue that the results could
not be reproduced due to changes in the isolates
(uncloned material) possibly introduced during cul-
turing between Experiments A and B. However, in
this particular example, it seems more likely that the
amastigote puriﬁcation step present in Experiment A
but absent in Experiment B, is (partly) responsible
for the diﬀerences in amastigote expression proﬁles
between Experiments A and B.
Characterization of promastigotes is less
challenging; these extracellular parasites can easily
be cultured and harvested with minimal risk of
aﬀecting their biological status. Gene expression
proﬁles could be reproduced with the experimental
procedures used here. However, as in the amastigote
model, expression levels may vary throughout the
in vitro diﬀerentiation from procyclic to metacyclic
form (observed for 9 out of 13 tested genes).
Changing gene expression proﬁles during promasti-
gote diﬀerentiation has been reported before
and this phenomenon is believed to be part of the
molecular changes that take place to pre-adapt
the parasite for transmission and survival in the
vertebrate host (Sacks, 1989; Saxena et al. 2003;
Akopyants et al. 2004; Almeida et al. 2004; Cohen-
Freue et al. 2007). The in vitro diﬀerentiation rates
of recently isolated parasites can diﬀer signiﬁcantly
(unpublished observations), and thus it seems
advisable to study expression-curves rather than
single-point measurements. Expression-curves also
confer the robustness required for expression
proﬁling Leishmania, where, as discussed before,
diﬀerences in expression level are often much lower
than in other eukaryotes (Akopyants et al. 2004;
Almeida et al. 2004; Duncan, 2004). While one
particular measurement may not be signiﬁcantly
diﬀerent between diﬀerent strains; the picture of
multiple measurements can reveal a signiﬁcant
diﬀerential expression regulation as is seen with
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the genes AQP1 and GCS for the 2 strains studied
here.
Gene expression studies on promastigotes cannot
replace expression studies on intracellular amasti-
gotes, as the latter provides unique information on
the clinical relevant form of the parasite at the time
of interaction with the host-cell. However, promasti-
gote expression-curves can provide complementary
information on the cell biological ﬂexibility of
the parasite. More speciﬁcally, the promastigote
expression-curves capture the degree of mRNA
abundance regulation during in vitro diﬀerentiation
in a standardized environment and as such reﬂect
the characteristic adaptive capacity of an isolate. The
expression-curves of the two isolates tested here
suggest that diﬀerent isolates can present with a
diﬀerential degree of regulation (adaptive capacity)
which in turn might be linked to diﬀerential pheno-
types.
In their natural context, Leishmania are charac-
terized by a tremendous phenotypic diversity regard-
ing vector-speciﬁcity, virulence, drug susceptibility
etc. This diversity contrasts with the relative struc-
tural conservation of Leishmania genomes (Peacock
et al. 2007). Possibly, Leishmania’s natural pheno-
typic diversity lies in diﬀerential features down-
stream of the genome, in the transcriptome or in the
proteome. Consequently, gene expression proﬁling
could play an essential role in the characterization of
phenotypic distinct Leishmania isolates. This study
demonstrated that highly standardized methods
are required for reliable comparative analyses. We
believe it is particularly essential to adopt methods
that conserve the environment of the parasite and
take into account the ﬂuctuation of gene expression
levels during the life-cycle of the parasite. Following
these guidelines, a proﬁling assay was developed for
promastigotes, but further studies are still required
to achieve a similar highly standardized method for
intracellular amastigotes.
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